# A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia

> **NCT00686140** · NA · COMPLETED · sponsor: **Beijing HuiLongGuan Hospital** · enrollment: 200 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** celecoxib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00686140
- **Lead sponsor:** Beijing HuiLongGuan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-12
- **Final completion:** 2008-03
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686140, "A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00686140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*